SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021065
Filing Date
2018-08-09
Accepted
2018-08-09 16:17:21
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20180630.htm 10-Q 1412922
2 EX-31.1 abio-ex311_7.htm EX-31.1 8583
3 EX-31.2 abio-ex312_8.htm EX-31.2 8541
4 EX-32.1 abio-ex321_6.htm EX-32.1 11188
  Complete submission text file 0001564590-18-021065.txt   4348740

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20180630.xml EX-101.INS 840286
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20180630.xsd EX-101.SCH 34987
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20180630_cal.xml EX-101.CAL 29392
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20180630_def.xml EX-101.DEF 85798
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20180630_lab.xml EX-101.LAB 271914
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20180630_pre.xml EX-101.PRE 196657
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 181005264
SIC: 2835 In Vitro & In Vivo Diagnostic Substances